Frost & Sullivan Publishes Q32018 Update Report on RedHill Biopharma Ltd. RedHill published additional data from MAP US Phase III study of RHB104 in Crohn's Disease; Steadystate sales in GI drugs; target price unchanged

Equity Research is published in the framework of the Tel Aviv Stock Exchange TASE Analysis Program TEL AVIV Israel Nov. 23 2018 PRNewswire The TASE analysis project was launched in 2016 ...